Health Lumos Diagnostics enters US commercial growth phase targeting a billion dollar opportunity By Ephrem Joseph 05/08
Health Actinogen Medical targets Alzheimer’s treatment gap in projected $20BN market By Proactive 05/08
Health Actinogen Medical targets Alzheimer’s treatment gap in projected $20BN market By Jonathan Jackson 05/08
Health Percheron Therapeutics Phase II progress highlighted by Edison with 5.5-cent valuation By Ephrem Joseph 05/08
Mining Small Cap Watch: Mastermyne lands major contract and BlinkLab advances ADHD diagnostic platform By Jonathan Jackson 05/08
Health Amplia Therapeutics partners with Lilly on lung cancer combination trial By Jonathan Jackson 04/08
Health Lumos Diagnostics secures US$768,000 FebriDx order as US commercial rollout gathers pace By Ephrem Joseph 04/08
Health Actinogen Medical advances pivotal XanaMIA trial towards November readout - ICYMI By Jonathan Jackson 01/08
Health Percheron Therapeutics targets clinical return for HMBD-002 after productive June quarter By Jonathan Jackson 31/07
Mining Small Cap Watch: Explorers and developers advance key programs during June quarter By Jonathan Jackson 31/07
Health Recce Pharmaceuticals positioned for US$66.9 billion US biodefence strategy By Ephrem Joseph 30/07
Health Actinogen Medical keeps pivotal Alzheimer’s trial on track for November readout By Jonathan Jackson 30/07
Health Lumos Diagnostics expands FebriDx reach into Romania through Alpha Medical distribution deal By Ephrem Joseph 30/07
Health Imricor launches US commercial operations with Rady Children’s as first hospital customer By Jonathan Jackson 27/07
Health Lumos Diagnostics caps FY26 with FebriDx revenue up 875% and US rollout gaining momentum By Jonathan Jackson 27/07
Health Forte Biosciences shares surge after argenx agrees to acquire company for $2.2B By Proactive 27/07
